Dermatological Advances 2009
December 3, 2009 at 9:30 AM - December 4, 2009 at 5:30 PM
BSG HOUSE 226-236 City Road, London
Visiongain’s Dermatological Advances 2009 conference, will examine the commercial drivers, and key innovations in drug development that are driving this market in a positive direction. This conference will facilitate high level of professional understanding on strategies employed by pharma and biotech companies to develop and market products in this highly exciting market sector. Our impressive line up of speakers include: Harish Mahalingam, Associate Director - Global Medical Affairs, Novartis Consumer Health; Prof Jana Hercogová, President, Czech Academy of Dermatology & Chair, Communication Committee, EC International Society of Dermatology; Marc Princivalle, Head of Risk Assessment EMEA - Director of Toxicology, Stiefel Laboratories; Prof Torello Lotti, MD & Chair, Dermatology Dept. - University of Florence & President, International Society of Dermatology; Lorna Mitchell, Medicinal Chemist, Pfizer; Joep Schoemaker, Senior Clinical Project Scientist, Schering Plough Research Institute
Event Owner: Maninder Paul (Marketing Project Manager at GSMA)

Updates

Tomasz Zawislak (Business Development Manager - Dermatology at Sanitas Group) will be attending.
Tatiana Salla (Meeting and Events at Guoman & Thistle hotels) will be attending.
Lorna Mitchell (Principal Scientist at Epizyme) will be attending.
Sharon Turner (Marketing at Almirall) will be attending.
Harish Mahalingam, PhD (Head, Global Medical Affairs (Digestive Health), Novartis Consumer Health) will be attending.
kirsten Davie (Delegate Sales Executive at Visiongain) will be attending.
Marc Princivalle (Director of Toxicology (ERT), Head of Preclinical Safety Assessment, EMEA at Stiefel, a GSK Company) will be attending.
Maninder Paul (Marketing Project Manager at GSMA) . created this event
Show More...
Become a LinkedIn member. It's free!
Network with others attending this event
Attendees by company
Sanitas Group
1
Guoman & Thistle hotels
1
Epizyme
1
Ashfield In2Focus
1
Novartis Consumer Health
1